Man Li

Xiamen University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

11h-index447citations25works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ubiquitin and proteasome pathways(5), RNA modifications and cancer(5), Cancer-related Molecular Pathways(3), Ferroptosis and cancer prognosis(3), Advanced Breast Cancer Therapies(3)

Publications25 total

Chinese expert consensus on clinical diagnosis and treatment of breast cancer targeting HER2
Translational Breast Cancer Research·2025· 1 citedOpen Access
Corrigendum to “MED27 promotes melanoma growth by targeting AKT/MAPK and NF/κB/iNOS signaling pathway” [Cancer Lett. 373(1) (2016) 77-87 PMID 26797421]
Cancer Letters·2025
Two-photon photosensitizer for specific targeting and induction of tumor pyroptosis to elicit systemic immunity-boosting anti-tumor therapy
Biomaterials·2025· 7 cited
Abemaciclib plus non-steroidal aromatase inhibitor or fulvestrant in women with HR+/HER2− advanced breast cancer: Final results of the randomized phase III MONARCH plus trial
Chinese Medical Journal·2024· 1 citedOpen Access
MiR-181c-5p Regulates Lung Adenocarcinoma Progression via Targeting PRKN
Biochemical Genetics·2023· 3 cited
A systematic review and meta-analysis of BRCA1/2 mutation for predicting the effect of platinum-based chemotherapy in triple-negative breast cancer
The Breast·2022· 16 citedOpen Access
Prognostic and Immune Implications of a Novel Pyroptosis-Related Five-Gene Signature in Breast Cancer
Frontiers in Surgery·2022· 8 citedOpen Access
Correction to: Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity
Journal of Experimental & Clinical Cancer Research·2021Open Access
Identification of differentially expressed genes-related prognostic risk model for survival prediction in breast carcinoma patients
Aging·2021· 8 citedOpen Access
Genotype characterization and delayed loss of ambulation by glucocorticoids in a large cohort of patients with Duchenne muscular dystrophy
Orphanet Journal of Rare Diseases·2021· 32 citedOpen Access
TIAM1 Upregulation Confers NVP-BEZ235 Resistance to Breast Cancer Cells Through FGFR/STAT3 Pathway
Biochemical Genetics·2020· 9 cited
Inhibition of p62/SQSTM1 sensitizes small‐cell lung cancer cells to cisplatin‐induced cytotoxicity by targeting NEDD9 expression
Molecular Carcinogenesis·2020· 10 cited
Engineering Corynebacterium glutamicum for Geraniol Production
Transactions of Tianjin University·2020· 11 cited
The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer
Cell Death and Differentiation·2020· 55 citedOpen Access
Identifying novel oncogenic <i>RET</i> mutations and characterising their sensitivity to RET-specific inhibitors
Journal of Medical Genetics·2020· 11 cited
FSIP1 is correlated with estrogen receptor status and poor prognosis
Molecular Carcinogenesis·2019· 8 cited
RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast cancer cells and affects cell aggressiveness
Carcinogenesis·2019· 20 citedOpen Access
Activation of Aurora A kinase increases YAP stability via blockage of autophagy
Cell Death and Disease·2019· 61 citedOpen Access
Prognostic significance of LAPTM4B and p27kip1 expression in triple-negative breast cancer
Cancer Biomarkers·2019· 12 citedOpen Access
Overexpression of 14‑3‑3ζ in lung tissue predicts an improved outcome in patients with lung adenocarcinoma
Oncology Letters·2018· 1 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Zuowei Zhao(5), Lingzhi Xu(4), Gena Huang(4), Tao Qin(3), Silei Sui(3), Chen Song(3), Kainan Wang(3), Siwen Sun(2), Ning Li(2), Ranran Tang(2), Xiangdong Xu(2), Wenjing Yang(2), Wendan Yu(2), Shuai Hou(2), Xuan Yang(2), Zhipeng Tang(2), Shilei Zhao(2), Yi‐Ming Chen(2), Xiangsheng Xiao(2), Wei Guo(2)